Encyclopedia

  • Neuronal damage induced by ß-N-oxalylamino-l-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline
  • Add time:09/08/2019         Source:sciencedirect.com

    The neurotoxin ß-N-oxalylamino-l-alanine (BOAA), found in Lathyrus sativus seeds, is thought to be the causative agent of neurolathyrism. We have investigated the in vivo mechanism of action of BOAA by focal injection (1 μl) in the dorsal hippocampus of male Wistar rats and comparing the pathological outcome with the effects of injections (1 μ1) of α-amino-3-hydroxy-5-methyl-isoxazole-4-propionate (AMPA), kainate (KA) or N-methyl-d-aspartate (NMDA). Cellular damage induced by the excitatory amino acids in the pyramidal (CA1-CA4) and dentate granule neurones (DG) was assessed histologically 24 h after the injection. The study shows that BOAA (50 nmol) induces hippocampal toxicity with a highly selective pattern of regional cellular damage. The CA1, CA4 and DG subfields show 70–90% neuronal injury whereas CA2 and CA3 show only minimal damage. This pattern of cellular damage is similar to that induced by AMPA (1 nmol) and NMDA (25 nmol) but not KA (0.5 nmol).BOAA-induced neurotoxicity is prevented in a dose-dependent manner by focal co-injection of the non-NMDA receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) (1–25 nmol) but not by a dose of MK-801 (3 mg/kg i.p.) which is neuroprotective against an injection of NMDA. Delayed focal injections of NBQX (25 nmol) up to 2 h after the BOAA injection result in a significant protection of all pyramidal and granular cell regions.These results indicate that the in vivo hippocampal toxicity of BOAA is mediated by AMPA receptors rather than by KA or NMDA receptors. Neurones in the rat hippocampus do not die immediately when exposed to BOAA but via a delayed process involving sustained AMPA receptor activation. Excitotoxic processes acting via AMPA receptors may play a role in the chronic loss of motor neurones seen in amyotrophic lateral sclerosis.

    We also recommend Trading Suppliers and Manufacturers of 3-SULFAMOYL-L-ALANINE (cas 18625-03-1). Pls Click Website Link as below: cas 18625-03-1 suppliers


    Prev:X-ray crystallographic conformational study of 5′-O-[N-(l-alanyl)-sulfamoyl]adenosine, a substrate analogue for alanyl-tRNA synthetase
    Next: Silver-based ionic liquid as separation media: Supported liquid membrane for facilitated methyl linolenate transport)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View